Variant cell surface molecule associated with cancer

   
   

The protein and nucleic acid sequences of mesovt2, specific antibodies thereto, methods for targeting and/or inhibiting the growth of cells bearing mesovt2, and methods of use of mesovt2 for diagnosing malignancy are provided. Methods of use of the mesovt2 antibodies in the treatment of certain cancers, particularly cancers that have increased cell surface expression of the mesovt2 antigen, such as pancreatic adenocarcinoma, lung carcinoma, and ovarian cancer, also are provided. The invention also relates to cells expressing the monoclonal antibodies, derivatives, and fragments.

As seqüências da proteína e do ácido nucleic de mesovt2, de antibodies específicos a isso, de métodos para alvejar e/ou inibir o crescimento das pilhas que carregam mesovt2, e de métodos do uso de mesovt2 para diagnosticar o malignancy são fornecidas. Os métodos do uso dos antibodies mesovt2 no tratamento de determinados cancers, particularmente os cancers que aumentaram a expressão da superfície da pilha do antígeno mesovt2, tal como o adenocarcinoma pancreatic, o carcinoma do pulmão, e o cancer ovarian, são fornecidos também. A invenção relaciona-se também às pilhas que expressam os antibodies, os derivatives, e os fragmentos monoclonal.

 
Web www.patentalert.com

< Interferon variants with improved properties

< Interleukin-7 molecules with altered biological properties

> Polysaccharide gum and process for its manufacture

> Cct protein expression promoter

~ 00166